These findings, consistent with the previous study (Huang et al., 2017) and our clinical observations in AD patients, indicate that increase of serum albumin may alleviate the neurotoxicity induced by unconjugated bilirubin that enters into the brain in AD. The gene discussed is ALB; the disease is Alzheimer disease.